Evaluation of ureterorenoscopic stone therapy - results with regard to complications, quality of life and stone-free rate

• Conditions: N20; Calculus of kidney and ureter

• Registration Number: DRKS00007668
• Lead Sponsor: Ruppiner Kliniken GmbH / Medizinische Hochschule Theodor Fontane

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-09
• Study Completion: 2015-09-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 309

Inclusion Criteria

Consent-capable patient who undergoes a ureterorenoscopic stone therapy

Exclusion Criteria

Incapacitated patients

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life and complications after ureterorenoscopic stone therapy (URS). <br>Assessing Quality of Life with the Health Survey SF-8-Questionnaire and IPSS 30 days postoperatively. Detection of complications after Clavien-Dindo (grade 0-5) perioperatively and 30 days postoperatively.

Secondary Outcome Measures

Name	Time	Method
Reintervention after URS